Nurse Practitioner in Holyoke, CO Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Derek Reed Doorn, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1001 E Johnson St, Holyoke, CO 80734 Phone: 970-854-2241 |
 Jessica Leigh Bullard, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1001 E Johnson St, Holyoke, CO 80734 Phone: 970-854-2500 Fax: 970-854-3440 |
Mrs. Jessica Rose Skomp, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1001 E Johnson St, Holyoke, CO 80734 Phone: 970-854-2500 |
Mrs. Deana Dawn O'gorman, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1001 E Johnson St, Holyoke, CO 80734 Phone: 970-854-2241 Fax: 970-854-3440 |
News Archive
New understanding of degeneration of brain cells in patients with Alzheimer's, Huntington's, and Parkinson's diseases
A ground-breaking new research approach to understanding the cellular processes of Alzheimer's and other degenerative diseases has revealed a promising pathway to the development of new types of drugs for these diseases.
Patients with hearing, vision and speech disabilities to be provided with auxiliary aids and services
Patients with hearing, vision, and speech disabilities, who receive care at University of Utah Hospitals & Clinics, will be screened and provided with auxiliary aids and services as required by federal law under a Resolution Agreement reached with the U.S. Department of Health and Human Services (HHS).
Research study on teens who underwent laparoscopic bypass surgery
According to a recent study of clinical characteristics of teens who underwent laparoscopic Roux-en-Y gastric bypass surgery from 2002 until 2007, doctors may have a much narrower window of opportunity to reverse morbid obesity in teens than previously thought.
Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.
Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.
› Verified 7 days ago